B precursor type acute leukaemia and Blast cell count increased
Summary:
Blast cell count increased is found among people with B precursor type acute leukaemia, especially for people who are male, 10-19 old.
The study analyzes which people have Blast cell count increased with B precursor type acute leukaemia. It is created by eHealthMe based on reports of 34 people who have B precursor type acute leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is B precursor type acute leukaemia?
B precursor type acute leukaemia (lymphoid cancer) is found to be associated with 31 drugs and 106 conditions by eHealthMe. Check the latest studies of B precursor type acute leukaemia.
What is Blast cell count increased?
Blast cell count increased is found to be associated with 114 drugs and 179 conditions by eHealthMe. Check the latest studies of Blast cell count increased.
34 people who have B Precursor Type Acute Leukaemia and Blast Cell Count Increased are studied.

Gender of people who have B Precursor Type Acute Leukaemia and experienced Blast Cell Count Increased *:
- female: 44.44 %
- male: 55.56 %
Age of people who have B Precursor Type Acute Leukaemia and experienced Blast Cell Count Increased *:
- 0-1: 0.0 %
- 2-9: 23.81 %
- 10-19: 38.1 %
- 20-29: 0.0 %
- 30-39: 9.52 %
- 40-49: 14.29 %
- 50-59: 4.76 %
- 60+: 9.52 %
Common co-existing conditions for these people *:
- Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 2 people, 5.88%
- Precursor B-Lymphoblastic Lymphoma Refractory (precursor b-cell cancer- refractory): 1 person, 2.94%
Common drugs taken by these people *:
- Blincyto: 30 people, 88.24%
- Decadron: 4 people, 11.76%
- Iclusig: 2 people, 5.88%
- Oxycontin: 1 person, 2.94%
- Oxycodone: 1 person, 2.94%
- Methotrexate: 1 person, 2.94%
- Meropenem: 1 person, 2.94%
- Maxipime: 1 person, 2.94%
- Cyclophosphamide: 1 person, 2.94%
- Ambisome: 1 person, 2.94%
Common symptoms for these people *:
- Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 14 people, 41.18%
- Fever: 13 people, 38.24%
- Pain In Extremity: 4 people, 11.76%
- Headache (pain in head): 4 people, 11.76%
- High Blood Pressure: 3 people, 8.82%
- Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 3 people, 8.82%
- Thrombocytopenia (decrease of platelets in blood): 3 people, 8.82%
- Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 3 people, 8.82%
- Joint Pain: 2 people, 5.88%
- Central Nervous System Leukaemia (cancer of central nervous system): 2 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Blast cell count increased?
- Check whether Blast cell count increased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- B precursor type acute leukaemia (3,936 reports)
- Blast cell count increased (1,224 reports)
All the drugs that are associated with Blast cell count increased:
- Blast cell count increased (114 drugs)
All the conditions that are associated with Blast cell count increased:
- Blast cell count increased (179 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Blast cell count increased and B precursor type acute leukaemia, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Angiomyolipoma and Renal Mass - a second ago
- Acute Myeloid Leukaemia Aggravated and Dilatation Ventricular - 8 seconds ago
- Drug interactions of Allegra Allergy and Xiidra - 14 seconds ago
- Could Ceftriaxone cause Hallucinations? - 16 seconds ago
- Could Pantoprazole Sodium cause Ear Discomfort? - 17 seconds ago
- Acute Myeloid Leukaemia and Platelet Count Increased - 17 seconds ago
- Could Enhertu cause Haemoglobin Decreased? - 23 seconds ago
- Could Skyrizi cause The Flu? - 29 seconds ago
- Bipolar Disorder and Dyskinesia - 30 seconds ago
- Abdominal Pain Upper and Dyspnea - 45 seconds ago